Mersana Therapeutics Inc

Mersana Therapeutics Inc

MRSN

Market Cap$36.27M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Mersana Therapeutics IncMersana Therapeutics Inc-0.5-240%--1.5
$-1.14

Current Fair Value

485.2% downside

Overvalued by 485.2% based on the discounted cash flow analysis.

Share Statistics

Market cap$36.27 Million
Enterprise Value$-21,207,379.00
Dividend Yield$0 (0%)
Earnings per Share$-0.56
Beta0.82
Outstanding Shares124,466,113

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-0.49
PEG-1.96
Price to Sales-
Price to Book Ratio-0.3
Enterprise Value to Revenue-0.62
Enterprise Value to EBIT0.35
Enterprise Value to Net Income0
Total Debt to Enterprise-2.11
Debt to Equity-1.45

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Mersana Therapeutics Inc

CEO: Anna Protopapas